| 496 |
Centers for Disease Control and Prevention |
Html |
en |
Possible Side-effects from Vaccines |
Any vaccine can cause side effects. For the most part these are minor (for example, a sore arm or low-grade fever) and go away within a few days. Listed below are vaccines licensed in the United States and side effects that have been associated with each of them. |
| doses | 0.350184 |
| death | 0.335756 |
| vaccines | 0.422174 |
| rotavirus vaccine | 0.311061 |
| vision changes | 0.44157 |
| fever | 0.421549 |
| flu vaccine | 0.31094 |
| shot | 0.517698 |
| remote chance | 0.419566 |
| moderate problems | 0.355524 |
| severe allergic reaction | 0.765018 |
| severe problems | 0.393389 |
| anthrax vaccine recipients | 0.303565 |
| vaccine safety site | 0.549318 |
| pain | 0.384187 |
| Td vaccine | 0.304469 |
| vaccine safety web | 0.323678 |
|
| DTaP vaccine | 0.324165 |
| medicine | 0.427819 |
| mild problems | 0.452628 |
| severe allergic reactions | 0.454603 |
| severe pain | 0.347928 |
| Vaccine Information Statements | 0.311976 |
| people | 0.468094 |
| medical procedure | 0.433552 |
| vaccine | 0.99366 |
| person | 0.331453 |
| reactions | 0.500757 |
| information | 0.470173 |
| page | 0.370982 |
| redness | 0.310828 |
| MMR vaccine | 0.312801 |
| Vaccine Safety website | 0.305288 |
| problems | 0.80886 |
|
CLICK HERE |
| 4735 |
Centers for Disease Control and Prevention |
Html |
en |
Epidemiology & Geographic Distribution - Eastern Equine Encephalitis |
Eastern Equine Encephalitis is a rare disease that is caused by a virus spread by infected mosquitoes.
|
| North Carolina | 0.341327 |
| Gulf Coast | 0.339501 |
| human EEEV infections | 0.356308 |
| Arboviral Diseases Branch | 0.451298 |
| equine encephalitis virus | 0.927372 |
| human cases | 0.287406 |
| average annual incidence | 0.435711 |
| Great Lakes | 0.342415 |
| Disease Control | 0.326898 |
| virus neuroinvasive disease | 0.560428 |
| state health departments | 0.333091 |
| EEEV activity | 0.290094 |
| western equine encephalitis | 0.391036 |
| recreational activities | 0.281156 |
| greatest risk | 0.277827 |
| primary transmission cycle | 0.345725 |
| Florida | 0.239005 |
| swampy areas | 0.285807 |
| severe disease | 0.285177 |
| Great Lakes region | 0.3347 |
| national surveillance case | 0.334686 |
| page | 0.309052 |
| outdoor work | 0.281185 |
| Puerto Rico | 0.261842 |
| EEEV transmission | 0.278487 |
|
| United States | 0.343992 |
| endemic areas | 0.280838 |
| life-long immunity | 0.27843 |
| La Crosse virus | 0.361783 |
| human populations | 0.28184 |
| Eastern equine encephalitis | 0.745504 |
| PDF | 0.264388 |
| data table | 0.398117 |
| neuroinvasive disease cases | 0.453872 |
| North Dakota | 0.266121 |
| New York | 0.404611 |
| Rhode Island | 0.332541 |
| significant cross-immunity | 0.272122 |
| Print only version | 0.333595 |
| South Dakota | 0.268261 |
| Eastern seaboard | 0.274669 |
| Gulf Coast states | 0.332136 |
| New Jersey | 0.3342 |
| freshwater hardwood swamps | 0.334467 |
| infected mosquito | 0.283626 |
| New Mexico | 0.27593 |
| West Nile virus | 0.361055 |
| Human EEEV cases | 0.371964 |
| New Hampshire | 0.279537 |
|
CLICK HERE |
| 5761 |
Centers for Disease Control and Prevention |
Html |
en |
N-Phenyl-beta-naphthylamine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7007 |
Centers for Disease Control and Prevention |
Html |
en |
Section 101 of the Tobacco Control Act - Amendment of Federal Food, Drug, and Cosmetic Act FDCA |
null |
| et seq. | 0.358847 |
| rr | 0.245803 |
| subsection | 0.287723 |
| dietary supplement | 0.360886 |
| U.S.C. | 0.274396 |
| Tobacco Control Act | 0.902734 |
| section | 0.385172 |
| raw materials | 0.370766 |
| drug | 0.498629 |
| Amendment | 0.307238 |
| Tobacco Products | 0.591361 |
| term | 0.275112 |
| end | 0.23707 |
|
| medical device | 0.351576 |
| Cosmetic Act | 0.870991 |
| combination product | 0.342435 |
| tobacco product | 0.625912 |
| biologic | 0.241519 |
| Definition | 0.237467 |
| Federal Food | 0.903539 |
| article | 0.271489 |
| FDA Authority | 0.362426 |
| component | 0.266097 |
| FDCA | 0.286057 |
| human consumption | 0.374618 |
|
CLICK HERE |
| 7125 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Italy |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 9835 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Physical Activity During Recess Outdoors and Indoors Among Urban Public School Students, St. Louis, Missouri, 2010"2011 - CDC |
We measured the quantity and intensity of physical activity in 106 urban public school students during recess outdoors, recess indoors in the gym, and recess indoors in the classroom. |
| recess outdoors | 0.584468 |
| average heart rate | 0.389688 |
| accelerometer pedometers | 0.391909 |
| recess location | 0.629166 |
| public school students | 0.392302 |
| physical education curricula | 0.367955 |
| physical activity quantity | 0.407806 |
| pedometer-determined physical activity | 0.383578 |
| moderate-to-vigorous physical activity | 0.406227 |
| M. Physical activity | 0.38248 |
| physical activity guidelines | 0.431755 |
| outdoor recess | 0.723281 |
| blood pressure | 0.433334 |
| indoor recess | 0.576427 |
| risk factors | 0.372783 |
| Sci Sports Exerc | 0.381129 |
| physical activity intensity | 0.405355 |
| recess period | 0.684162 |
| recess locations | 0.538529 |
| recess period outdoors | 0.557111 |
| single recess period | 0.524565 |
| poor physical fitness | 0.378577 |
| deviation heart rate | 0.368885 |
| recess | 0.747474 |
|
| quality physical activity | 0.387801 |
| Recess choices | 0.510246 |
| recess indoors | 0.536705 |
| students | 0.404458 |
| single recess observation | 0.516944 |
| heart rate monitors | 0.409026 |
| indoor recess opportunities | 0.512473 |
| Med Sci Sports | 0.379974 |
| daily physical activity | 0.419399 |
| recess observations | 0.594969 |
| St. Louis | 0.449145 |
| total steps | 0.4216 |
| school students | 0.396405 |
| 20-minute recess period | 0.541206 |
| heart rate | 0.566897 |
| recess periods | 0.584754 |
| E600 heart rate | 0.369186 |
| Physical Therapy Research | 0.371327 |
| physical activity | 0.912376 |
| Washington University School | 0.401798 |
| school-based physical activity | 0.43528 |
| high blood pressure | 0.402018 |
| et al | 0.367331 |
| physical education class | 0.369163 |
|
CLICK HERE |
| 11359 |
Centers for Disease Control and Prevention |
Html |
en |
Questions and Answers on Ebola | Ebola Hemorrhagic Fever |
null |
| CDC | 0.75553 |
| CDC’s Travelers | 0.567103 |
| West Africa region | 0.507452 |
| affected countries | 0.484202 |
| Health Presbyterian Hospital | 0.494586 |
| Health Alert Notice | 0.500245 |
| Ebola virus | 0.581279 |
| Texas Health Presbyterian | 0.547987 |
| New York City | 0.479583 |
| Ebola outbreak | 0.751431 |
| contact | 0.495474 |
| public health risk | 0.508509 |
| additional cases | 0.623495 |
| response capacities | 0.488841 |
| sick people | 0.586963 |
| ongoing surveillance | 0.483059 |
| body fluids | 0.768794 |
| public health officials | 0.495951 |
| travelers | 0.636623 |
| public health experts | 0.512219 |
| Ebola patients | 0.585518 |
| Ebola | 0.965879 |
| CDC officials | 0.520569 |
| U.S. healthcare workers | 0.492806 |
|
| enhanced entry screening | 0.481214 |
| Health Ebola webpage | 0.716554 |
| United States | 0.871652 |
| Sierra Leone | 0.495138 |
| U.S. public health | 0.498171 |
| sick travelers | 0.629851 |
| Africa Ebola outbreak | 0.720087 |
| local health departments | 0.572379 |
| public health | 0.746389 |
| visit CDC | 0.572722 |
| Widespread transmission | 0.535991 |
| Border Protection | 0.481705 |
| public health actions | 0.505914 |
| West Africa Ebola | 0.711134 |
| necessary public health | 0.503121 |
| public health field | 0.507818 |
| close personal contact | 0.4836 |
| Monitoring Travelers | 0.495687 |
| West Africa | 0.971107 |
| healthcare workers | 0.608514 |
| Ebola fact sheet | 0.642225 |
| male Ebola survivors | 0.621372 |
| dead bodies | 0.544592 |
| public health action | 0.573971 |
|
CLICK HERE |
| 11665 |
Centers for Disease Control and Prevention |
Html |
es |
Prueba del VIH - InformaciÓn BÁsica - HIV/AIDS |
Realizarse una prueba del VIH es la única forma de saber si se tiene el virus. En esta sección se responden algunas de las preguntas más comunes relacionadas con las pruebas del VIH, como los tipos de pruebas disponibles, los lugares donde se pueden realizar y qué esperar cuando vaya a hacerse la prueba. |
| ¿Otras personas | 0.396912 |
| Archivo Apple Quicktime | 0.336821 |
| alto riesgo | 0.507944 |
| Archivo Adobe PDF | 0.335855 |
| Ryan White | 0.377745 |
| pequeña cantidad | 0.3367 |
| Instituto Guttmacher | 0.326363 |
| profilaxis prexposición | 0.404147 |
| prueba anónima | 0.549158 |
| Archivo Microsoft | 0.409617 |
| general tarda | 0.339686 |
| Archivo Microsoft Word | 0.338115 |
| campaña inicia | 0.3264 |
| siguientes preguntas | 0.33748 |
| cuánto tiempo | 0.330351 |
| infección aguda | 0.352921 |
| VIH OraQuick | 0.722095 |
| reciente exposición | 0.336082 |
|
| Archivo Microsoft Excel | 0.335347 |
| suficientes antÃgenos | 0.343457 |
| HIV-1 Test System | 0.365323 |
| seguro médico | 0.872467 |
| relación monógama | 0.339307 |
| Bajo Precio | 0.36689 |
| importantes beneficios | 0.334727 |
| importante información | 0.326038 |
| Archivo Microsoft PowerPoint | 0.338407 |
| —por ejemplo | 0.329616 |
| Estados Unidos | 0.413924 |
| profilaxis posexposición | 0.424271 |
| única forma | 0.431903 |
| Archivo Zip Comprimido | 0.336555 |
| prueba casera | 0.515751 |
| resultados irán | 0.332601 |
| persona vih | 0.986022 |
|
CLICK HERE |
| 12019 |
Centers for Disease Control and Prevention |
Html |
en |
Possible Eradication of Wild Poliovirus Type 3 - Worldwide,2012 |
Olen M. Kew, PhD1, Stephen L. Cochi, MD2, Hamid S. |
| possible global interruption | 0.706464 |
| supplementary immunization activities | 0.671175 |
| WPV3 transmission | 0.724128 |
| environmental surveillance | 0.786683 |
| residual WPV3 infections | 0.728502 |
| Western Pacific Region | 0.883055 |
| Olen M. Kew | 0.704361 |
| AFP cases | 0.840966 |
| WPV3 eradication | 0.702595 |
| WPV3 clusters | 0.698805 |
| bivalent oral poliovirus | 0.662168 |
| indigenous WPV1 transmission | 0.72097 |
| Hamid S. Jafari | 0.704633 |
| Global Polio Eradication | 0.910015 |
| WPV3 | 0.795548 |
| Administered Tribal Area | 0.67455 |
| Polio Eradication Initiative | 0.905407 |
| World Health Organization | 0.854727 |
| Rudolf H. Tangermann | 0.700329 |
| case-to-infection ratio | 0.760495 |
| South-East Asia Region | 0.704554 |
| higher surveillance sensitivity | 0.702329 |
| 3Polio Eradication Department | 0.722463 |
| AFP surveillance | 0.78046 |
|
| Gregory L. Armstrong | 0.693597 |
| indigenous WPV serotypes | 0.669957 |
| Stephen L. Cochi | 0.861629 |
| Eric E. Mast | 0.70174 |
| genetic diversity | 0.680969 |
| Steven G.F. Wassilak | 0.697576 |
| oral poliovirus vaccine | 0.768431 |
| low case-to-infection ratio | 0.66759 |
| global interruption | 0.709376 |
| Ousmane M. Diop | 0.705769 |
| WPV3 cases | 0.66938 |
| long-range WPV3 exportations | 0.72416 |
| Pakistan | 0.664985 |
| public health emergency | 0.694079 |
| Nigeria | 0.696301 |
| 2Global Immunization Division | 0.676035 |
| nucleotide sequence divergence | 0.843423 |
| European Region | 0.707345 |
| WPV type | 0.768983 |
| distinct WPV3 genotypes | 0.736312 |
| World Health Assembly | 0.714878 |
| acute flaccid paralysis | 0.683284 |
| Global Polio Laboratory | 0.71539 |
| emergency action plans†| 0.665578 |
|
CLICK HERE |
| 15681 |
Centers for Disease Control and Prevention |
Html |
en |
Title | CDC Online Newsroom | CDC |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |